Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Nano Lett ; 23(12): 5497-5505, 2023 06 28.
Article in English | MEDLINE | ID: mdl-37300521

ABSTRACT

Nanostructured contrast agents are promising alternatives to Gd3+-based chelates in magnetic resonance (MR) imaging techniques. A novel ultrasmall paramagnetic nanoparticle (UPN) was strategically designed to maximize the number of exposed paramagnetic sites and r1 while minimizing r2, by decorating 3 nm titanium dioxide nanoparticles with suitable amounts of iron oxide. Its relaxometric parameters are comparable to those of gadoteric acid (GA) in agar phantoms, and the r2/r1 ratio of 1.38 at 3 T is close to the ideal unitary value. The strong and prolonged contrast enhancement of UPN before renal excretion was confirmed by T1-weighted MR images of Wistar rats after intravenous bolus injection. Those results associated with good biocompatibility indicate its high potential as an alternative blood-pool contrast agent to the GA gold standard for MR angiography, especially for patients with severe renal impairment.


Subject(s)
Contrast Media , Magnetic Resonance Angiography , Rats , Animals , Gadolinium , Rats, Wistar , Magnetic Resonance Imaging/methods , Chelating Agents
2.
Eur J Pharm Biopharm ; 159: 99-107, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33358940

ABSTRACT

Atherosclerosis is a non-resolving inflammatory condition that underlies major cardiovascular diseases.Recent clinical trial using an anti-inflammatory drug has showna reduction of cardiovascular mortality, but increased the susceptibility to infections. For this reason, tissue target anti-inflammatory therapies can represent a better option to regress atherosclerotic plaques. Docosahexaenoic acid (DHA) is a natural omega 3 fatty acidcomponentof algae oil and acts asaprecursor of several anti-inflammatory compounds, such the specialized proresolving lipid mediators(SPMs). During the atherosclerosis process, the inflammatory condition of the endothelium leads to the higher expression of adhesion molecules, such as Endothelial Cell Adhesion Molecule Plate 1 (PECAM-1 or CD31), as part of the innate immune response. Thus, the objective of this study was to develop lipid-core nanocapsules with DHA constituting the nucleus and anti-PECAM-1 on their surface and drive this structure to the inflamed endothelium. Nanocapsules were prepared by interfacial deposition of pre-formed polymer method. Zinc-II was added to bind anti-PECAM-1 to the nanocapsule surface by forming an organometallic complex. Swelling experiment showed that the algae oil act as non-solvent for the polymer (weight constant weight for 60 days, p > 0.428) indicating an adequate material to produce kinetically stable lipid-core nanocapsules (LNC). Five formulations were synthesized: Lipid-core nanocapsules containing DHA (LNC-DHA) or containing Medium-chain triglycerides (LNC-MCT), multi-wall nanocapsules containing DHA (MLNC-DHA) or containing MCT (MLNC-MCT) and the surface-functionalized (anti-PECAM-1) metal-complex multi-wall nanocapsules containing DHA (MCMN-DHA-a1). All formulations showed homogeneous macroscopic aspects without aggregation. The mean size of the nanocapsules measured by laser diffraction did not show difference among the samples (p = 0.241). Multi-wall nanocapsules (MLNC) showed a slight increase in the mean diameter and polydispersity index (PDI) measured by DLS, lower pH and an inversion in the zeta-potential (ξP) compared to LNCs. Conjugation test for anti-PECAM-1 showed 94.80% of efficiency. The mean diameter of the formulation had slightly increased from 160 nm (LCN-DHA) and 162 nm (MLNC-DHA) to 164 nm (MCMN-DHA-a1) indicating that the surface functionalization did not induce aggregation of the nanocapsules. Biological assays showed that the MCMN-DHA-a1 were uptaken by the HUVEC cells and did not decrease their viability. The surface-functionalized (anti- PECAM-1) metal-complex multi-wall nanocapsules containing DHA (MCMN-DHA-a1) can be considered adequate for pharmaceutical approaches.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Atherosclerosis/drug therapy , Docosahexaenoic Acids/administration & dosage , Nanocapsules/chemistry , Platelet Endothelial Cell Adhesion Molecule-1/antagonists & inhibitors , Drug Combinations , Drug Compounding/methods , Human Umbilical Vein Endothelial Cells , Humans , Lipids/chemistry , Organometallic Compounds/chemistry , Particle Size , Zinc/chemistry
3.
Micron ; 121: 21-25, 2019 06.
Article in English | MEDLINE | ID: mdl-30877951

ABSTRACT

Turkevich gold nanoparticles colloidal solutions undergo further changes after ageing for several weeks or months, and in most cases a spongy dark material can be observed suspended in the red solution. CytoViva® dark-field microscopy images and high resolution transmission electron micrographys (HRTEM) of the strange body played a central role and revealed a fibrous structure, consistent with cellulose, as commonly found in the cell-walls of many fungi. Surprisingly, the interior of the fibers are filled with gold nanoparticles, responsible for the high contrasting images obtained in this work. The fungi were replicated in the laboratory, characterized by Infrared Microscopy (FTIR) and revealed an ability to grow in gold-citrate media, even in dark and anaerobical conditions.

SELECTION OF CITATIONS
SEARCH DETAIL